117 related articles for article (PubMed ID: 11422805)
1. Expression of p53 protein as a prognostic indicator of reduced survival time in diffuse-type gastric carcinoma.
Liu XP; Tsushimi K; Tsushimi M; Oga A; Kawauchi S; Furuya T; Sasaki K
Pathol Int; 2001 Jun; 51(6):440-4. PubMed ID: 11422805
[TBL] [Abstract][Full Text] [Related]
2. P53-protein accumulation and MDM2-protein overexpression in gastric carcinomas. No apparent correlation with survival.
Kasper HU; Schneider-Stock R; Mellin W; Günther T; Roessner A
Pathol Res Pract; 1999; 195(12):815-20. PubMed ID: 10631716
[TBL] [Abstract][Full Text] [Related]
3. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.
Deveci MS; Deveci G
Gastric Cancer; 2007; 10(2):112-6. PubMed ID: 17577621
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
Ismail HM; Moneer M; El-Baradie M; Khorshid O; Touny A
J Egypt Natl Canc Inst; 2007 Jun; 19(2):147-57. PubMed ID: 19034345
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
[TBL] [Abstract][Full Text] [Related]
7. P53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type.
Roviello F; Marrelli D; Vindigni C; De Stefano A; Spina D; Pinto E
Ann Surg Oncol; 1999 Dec; 6(8):739-45. PubMed ID: 10622501
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein as a prognostic factor in patients with gastric cancer.
Victorzon M; Nordling S; Haglund C; Lundin J; Roberts PJ
Eur J Cancer; 1996 Feb; 32A(2):215-20. PubMed ID: 8664030
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
[TBL] [Abstract][Full Text] [Related]
11. Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma.
Maeta Y; Tsujitani S; Matsumoto S; Yamaguchi K; Tatebe S; Kondo A; Ikeguchi M; Kaibara N
Gastric Cancer; 2004; 7(2):78-84. PubMed ID: 15224193
[TBL] [Abstract][Full Text] [Related]
12. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
14. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.
Kim KW; Kim N; Choi Y; Kim WS; Yoon H; Shin CM; Park YS; Lee DH; Park YS; Ahn SH; Park DJ; Kim HH; Lee HS; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH
Gastric Cancer; 2021 Jul; 24(4):844-857. PubMed ID: 33598811
[TBL] [Abstract][Full Text] [Related]
15. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages.
Wu MS; Shun CT; Sheu JC; Wang HP; Wang JT; Lee WJ; Chen CJ; Wang TH; Lin JT
J Gastroenterol Hepatol; 1998 Mar; 13(3):305-10. PubMed ID: 9570245
[TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cyclin E and p53 expression in gastric carcinoma.
Sakaguchi T; Watanabe A; Sawada H; Yamada Y; Yamashita J; Matsuda M; Nakajima M; Miwa T; Hirao T; Nakano H
Cancer; 1998 Apr; 82(7):1238-43. PubMed ID: 9529014
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.
Joypaul BV; Hopwood D; Newman EL; Qureshi S; Grant A; Ogston SA; Lane DP; Cuschieri A
Br J Cancer; 1994 May; 69(5):943-6. PubMed ID: 8180028
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer.
Maehara Y; Oki E; Abe T; Tokunaga E; Shibahara K; Kakeji Y; Sugimachi K
Oncology; 2000 Feb; 58(2):144-51. PubMed ID: 10705241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
